Clinical trial
NRTI-Sparing Pilot Study
NCT00143689 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00143689 |
|---|---|
| Title | NRTI-Sparing Pilot Study |
| Official title | A Pilot Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor Sparing Regimen in Antiretroviral-Naïve, HIV-infected Patients |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Abbott Industry Boehringer Ingelheim CIHR Canadian HIV Trials Network |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV, Mitochondrial Toxicity |
| Intervention type | Drug |
| Interventions | lopinavir/ritonavir, nevirapine, Zidovudine, Lamivudine |
| Enrollment | 13 |
| Start date | Apr 1, 2002 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 26, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: